The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study
Open accessAbstract
BACKGROUND: Coronary computed tomography angiography (CCTA) is the first line investigation for chest pain, and it is used to guide revascularisation. However, the widespread adoption of CCTA has revealed a large group of individuals without obstructive coronary artery disease (CAD), with unclear prognosis and management. Measurement of coronary inflammation from CCTA using the perivascular fat attenuation index (FAI) Score could enable cardiovascular risk prediction and guide the management of individuals without obstructive CAD. The Oxford Risk Factors And Non-invasive imaging (ORFAN) study aimed to evaluate the risk profile and event rates among patients undergoing CCTA as part of routine clinical care in the UK National Health Service (NHS); to test the hypothesis that coronary arterial inflammation drives cardiac mortality or major adverse cardiac events (MACE) in patients with or without CAD; and to externally validate the performance of the previously trained artificial intelligence (AI)-Risk prognostic algorithm and the related AI-Risk classification system in a UK population. METHODS: This multicentre, longitudinal cohort study included 40 091 consecutive patients undergoing clinically indicated CCTA in eight UK hospitals, who were followed up for MACE (ie, myocardial infarction, new onset heart failure, or cardiac death) for a median of 2·7 years (IQR 1·4-5·3). The prognostic value of FAI Score in the presence and absence of obstructive CAD was evaluated in 3393 consecutive patients from the two hospitals with the longest follow-up (7·7 years [6·4-9·1]). An AI-enhanced cardiac risk prediction algorithm, which integrates FAI Score, coronary plaque metrics, and clinical risk factors, was then evaluated in this population. FINDINGS: In the 2·7 year median follow-up period, patients without obstructive CAD (32 533 [81·1%] of 40 091) accounted for 2857 (66·3%) of the 4307 total MACE and 1118 (63·7%) of the 1754 total cardiac deaths in the whole of Cohort A. Increased FAI Score in all the three coronary arteries had an additive impact on the risk for cardiac mortality (hazard ratio [HR] 29·8 [95% CI 13·9-63·9], p<0·001) or MACE (12·6 [8·5-18·6], p<0·001) comparing three vessels with an FAI Score in the top versus bottom quartile for each artery. FAI Score in any coronary artery predicted cardiac mortality and MACE independently from cardiovascular risk factors and the presence or extent of CAD. The AI-Risk classification was positively associated with cardiac mortality (6·75 [5·17-8·82], p<0·001, for very high risk vs low or medium risk) and MACE (4·68 [3·93-5·57], p<0·001 for very high risk vs low or medium risk). Finally, the AI-Risk model was well calibrated against true events. INTERPRETATION: The FAI Score captures inflammatory risk beyond the current clinical risk stratification and CCTA interpretation, particularly among patients without obstructive CAD. The AI-Risk integrates this information in a prognostic algorithm, which could be used as an alternative to traditional risk factor-based risk calculators. FUNDING: British Heart Foundation, NHS-AI award, Innovate UK, National Institute for Health and Care Research, and the Oxford Biomedical Research Centre.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Self-citationRosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citation2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Self-citationExtensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Colchicine in Patients with Chronic Coronary Disease
Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299 · cited 1×
“Evidence from clinical trials suggests that anti-inflammatory treatments like statins, 21 colchicine, 22 or anti-inteleukin-1β 23 reduce cardiovascular events.”
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Statistics in Medicine · doi:10.1002/sim.5958 · Cited by 1,852
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction
The SCOT-HEART Investigators (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805971 · Cited by 1,390
Oikonomou, E. K., Marwan, M., Desai, M. Y., Mancio, J., Alashi, A., Hutt Centeno, E., Thomas, S., Herdman, L., Kotanidis, C. P., Thomas, K. E., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31114-0 · Cited by 1,172
Self-citationDetecting human coronary inflammation by imaging perivascular fat
Antonopoulos, A. S., Sanna, F., Sabharwal, N., Thomas, S., Oikonomou, E. K., Herdman, L., Margaritis, M., Shirodaria, C., Kampoli, A.-M., Akoumianakis, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2658 · Cited by 1,093
Self-citation
Cited by
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.11.016 · Cited by 304
Self-citationArtificial intelligence in cardiovascular medicine: clinical applications
Lüscher, T. F., Wenzl, F. A., D’Ascenzo, F., Friedman, P. A., & Antoniades, C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae465 · Cited by 160
Self-citationWriting Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001423 · Cited by 122
Self-citationAntoniades, C., & Chan, K. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztaf048 · Cited by 1
Self-citation
Metadata
- Authors
- Chan, K., Wahome, E., Tsiachristas, A., Antonopoulos, A. S., Patel, P., Lyasheva, M., Kingham, L., West, H., Oikonomou, E. K., Volpe, L., Mavrogiannis, M. C., Nicol, E., Mittal, T. K., Halborg, T., Kotronias, R. A., Adlam, D., Modi, B., Rodrigues, J., Screaton, N., Kardos, A., Greenwood, J. P., Sabharwal, N., De Maria, G. L., Munir, S., McAlindon, E., Sohan, Y., Tomlins, P., Siddique, M., Kelion, A., Shirodaria, C., Pugliese, F., Petersen, S. E., Blankstein, R., Desai, M., Gersh, B. J., Achenbach, S., Libby, P., Neubauer, S., Channon, K. M., Deanfield, J., Antoniades, C., Thomas, S., Denton, J., Farral, R., Taylor, C., Qin, W., Kasongo, M., Anthony, S., Banning, A., Xie, C., Kharbanda, R. K., Pritchard, A., Halborg, T., Syed, N., Fry, S., Mathers, C., Rose, A., Hudson, G., Bajaj, A., Das, I., Deshpande, A., Rao, P., Lawday, D., Mirsadraee, S., Hudson, B., Berry, C., Marwan, M., Maurovich-Horvat, P., He, G.-W., Lin, W.-H., Fan, L.-J., Takahashi, N., Kondo, H., Dai, N., Ge, J., Koo, B.-K., Guglielmo, M., Pontone, G., Huck, D., Benedek, T., Rajani, R., Vilic, D., Aljazzaf, H., Mun, M. S., Benedetti, G., Preston, R. L., Raisi-Estabragh, Z., Connolly, D. L., Sharma, V., Grenfell, R., Bradlow, W., Schmitt, M., Serfaty, F., Gottlieb, I., Neves, M. F., Newby, D. E., Dweck, M. R., Hatem, S., Redheuil, A., Benetos, G., Beer, M., Granillo, G. A., Selvanayagam, J., Lopez-Jimenez, F., De Bosscher, R., Tavildari, A., Figtree, G., Danad, I., Shantouf, R., Kietselaer, B., Tousoulis, D., Dangas, G., Mehta, N. N., Kontanidis, C., Kunadian, V., & Fairbairn, T. A.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2024-06
- Volume
- 403
- Issue
- 10444
- Pages
- 2606-2618
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4399119006
- Cited by
- 290
- References
- 21
- FWCI
- 66.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. https://app.cochat.ai/papers/10.1016/s0140-6736(24)00596-8
- The paper
- Chan, K., Wahome, E., Tsiachristas, A., Antonopoulos, A. S., Patel, P., Lyasheva, M., Kingham, L., West, H., Oikonomou, E. K., Volpe, L., Mavrogiannis, M. C., Nicol, E., Mittal, T. K., Halborg, T., Kotronias, R. A., Adlam, D., Modi, B., Rodrigues, J., Screaton, N., . . . Fairbairn, T. A. (2024). Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. The Lancet. https://doi.org/10.1016/s0140-6736(24)00596-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.